At PolarityTE, our revolutionary platform induces cell and tissue polarity, creating uniquely functional tissue that mirrors natural development in the human body.
At PolarityTE, we are a translational regenerative medicine company aiming to spark a Paradigm Shift in clinical medicine and biomedical research.
We are looking to partner with people/companies who share our drive and ambition to change the landscape of medicine.
SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/13/17 --
PolarityTE™, Inc., ("Polarity") (NASDAQ: COOL) today announced the voting results from it special meeting (the "Meeting") held on March 10, 2017.